Learn from renowned clinical expert, George J. Alangaden, M.D., as he discusses how Henry Ford Health System (HFHS) implemented T2MR and the T2Candida Panel as part of their sepsis protocol for the ...

A new product developed by Lexington-based T2 Biosystems could dramatically improve the survival rate of trauma patients whose bodies are unable to control or stop bleeding. The innovative and ...

Bayer will use T2 Biosystems’ T2 Magnetic Resonance technology platform (T2MR ®) under a multiyear hemostasis research collaboration whose value was not disclosed. The collaboration, disclosed today ...

Please provide your email address to receive an email when new articles are posted on . T2 Biosystems is the first company to receive FDA-clearance for their T2Candida Panel and, more recently, their ...

LEXINGTON, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that Expert Review of Medical ...

T2 Biosystems, Inc. has signed a multi-year agreement to provide T2 Biosystems’ T2 Magnetic Resonance technology platform, or T2MR®, for Bayer’s research and development efforts in blood coagulation ...

Data presented at the Innovation Session analyzed the detection time of both T2Bacteria and T2 sepsis panels. High Detection Rate: The T2Bacteria Panel showed broad coverage, detecting 77% of all ...

When infection strikes, the human body strikes back. Yet that reaction often takes a patient down a more perilous path. The body’s severe inflammatory response can lead to sepsis, a potentially ...

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems today announced that it has filed a 510(k) premarket submission for T2Dx and T2Candida with the U.S. Food and Drug Administration (FDA). The premarket ...

Hospitals are beginning to use a new, more potent weapon against sepsis, the devastating condition that kills more than 25 percent of its victims and costs hospitals billions of dollars annually. In ...

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products designed to enable superior diagnostics, today announced the presentation of data highlighting the role ...